Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ICCR Addresses Cosmetic Labeling, Nanotechnology At First Meeting

This article was originally published in The Rose Sheet

Executive Summary

The International Cooperation on Cosmetics Regulation invites the cosmetics industry to generate and submit data showing that U.S. consumers understand the meaning of "trivial names" on product labeling

You may also be interested in...



PCPC: FDA Should Harmonize GMP Guidance With ISO Standard

While FDA used portions of ISO 22716 as a model for the 2013 update to its Good Manufacturing Practices draft guidance, the Personal Care Products Council feels international efforts toward GMP harmonization would be better served if the agency adopted ISO 22716 in its entirety.

ICCR Ushers Forth Updated Cosmetic GMP Guidelines From FDA

FDA’s draft revision of Cosmetic Good Manufacturing Practices takes into account international consensus formed through harmonization efforts under the International Cooperation on Cosmetics Regulations, says the agency. The recommendations update guidelines created in 1997 and revised in 2008.

FDA Seeks International Input On Sunscreen Monograph

With a final sunscreen rule targeted for the fall, FDA plans to discuss proposed requirements with regulators from the European Union, Canada and Japan at the International Cooperation on Cosmetics Regulation meeting in Toronto July 13-15

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015015

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel